{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:43:09Z","timestamp":1793256189792,"version":"4.5.0"},"reference-count":200,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["kidney-international.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.kint.2025.04.005","type":"journal-article","created":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T23:32:33Z","timestamp":1750289553000},"page":"555-571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference"],"prefix":"10.1016","volume":"108","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9805-9523","authenticated-orcid":false,"given":"Alberto","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7430-702X","authenticated-orcid":false,"given":"Jos\u00e9 Manuel","family":"Arreola Guerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C.N.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8015-9470","authenticated-orcid":false,"given":"Vivekanand","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6374-837X","authenticated-orcid":false,"given":"Holly","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne B.","family":"Nicholas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meda E.","family":"Pavkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9507-5301","authenticated-orcid":false,"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie P.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6233-2831","authenticated-orcid":false,"given":"Michael","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer M.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7369-7812","authenticated-orcid":false,"given":"Michel","family":"Jadoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2235-0103","authenticated-orcid":false,"given":"Katherine R.","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Alieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gloria","family":"Ashuntantang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petter","family":"Bjornstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian H.","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Carina Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Fioretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edouard L.","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ram\u00f3n","family":"Garc\u00eda-Trabanino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marvin","family":"Gonzalez-Quiroz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shang-Jyh","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie R.","family":"Ingelfinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Areef","family":"Ishani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H.","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kitty J.","family":"Jager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J.","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.B.","family":"Ananda Jayalal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stacey E.","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kalyesubula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kiryluk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerie A.","family":"Luyckx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michal L.","family":"Melamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borislava","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiadi E.","family":"Ndumele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene L.","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagnani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Saez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantelis A.","family":"Sarafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine K.","family":"Scammell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G.","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sol\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy L.","family":"St. Peter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duane","family":"Sunwold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Tonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Torra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhan","family":"Tu\u011flular","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Lekha","family":"Tummalapalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep","family":"Vilaseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Yee-Moon","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4S","key":"10.1016\/j.kint.2025.04.005_bib1","first-page":"S117","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib2","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.2337\/dc24-S003","article-title":"3. Prevention or delay of diabetes and associated comorbidities: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12882-021-02597-3","article-title":"Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990\u20132019: results from the global burden of disease study 2019","volume":"23","author":"Ke","year":"2022","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/ndt\/gfz174","article-title":"A single number for advocacy and communication-worldwide more than 850 million individuals have kidney diseases","volume":"34","author":"Jager","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib5","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000515541","article-title":"Tackling dialysis burden around the world: a global challenge","volume":"7","author":"Li","year":"2021","journal-title":"Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib7","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib8","article-title":"To include or not include: renal dialysis policy in the era of universal health coverage","volume":"368","author":"Teerawattananon","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2025.04.005_bib9","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.kint.2018.07.025","article-title":"The burden of chronic kidney disease and its major risk factors in Jamaica","volume":"94","author":"Kramer","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib10","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.kint.2022.12.015","article-title":"Our shared responsibility: the urgent necessity of global environmentally sustainable kidney care","volume":"104","author":"Stigant","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib11","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1016\/S0140-6736(18)31694-5","article-title":"Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories","volume":"392","author":"Foreman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib12","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.kint.2018.08.019","article-title":"The International Society of Nephrology's International Consortium of Collaborators on Chronic Kidney Disease of Unknown Etiology: report of the working group on approaches to population-level detection strategies and recommendations for a minimum dataset","volume":"95","author":"Caplin","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib13","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae053","article-title":"Decreased life expectancy: a health outcome not corrected by kidney replacement therapy that emphasizes the need for primary prevention of CKD","volume":"17","author":"Cordero","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib14","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"Cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.04.005_bib15","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0140-6736(20)30540-7","article-title":"The link between kidney disease and cancer: complications and treatment","volume":"396","author":"Malyszko","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib17","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1097\/MNH.0000000000000646","article-title":"Pain management in patients with chronic kidney disease and end-stage kidney disease","volume":"29","author":"Roy","year":"2020","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/j.kint.2025.04.005_bib18","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.kint.2016.07.013","article-title":"Infection in advanced chronic kidney disease leads to increased risk of cardiovascular events, end-stage kidney disease and mortality","volume":"90","author":"Cheikh Hassan","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib19","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2147\/JHL.S394088","article-title":"Bridging the \u201cknow-do\u201d gaps in five non-communicable diseases using a common framework driven by implementation science","volume":"15","author":"Donohue","year":"2023","journal-title":"J Healthc Leadersh"},{"key":"10.1016\/j.kint.2025.04.005_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2020.06.024","article-title":"Executive summary of the 2020 KDIGO diabetes management in CKD guideline: evidence-based advances in monitoring and treatment","volume":"98","author":"de Boer","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib22","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1038\/s41591-023-02296-6","article-title":"Heterogeneous aging across multiple organ systems and prediction of chronic disease and mortality","volume":"29","author":"Tian","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.04.005_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1004261","article-title":"Age- and sex-specific hospital bed-day rates in people with and without type 2 diabetes: a territory-wide population-based cohort study of 1.5 million people in Hong Kong","volume":"20","author":"Wu","year":"2023","journal-title":"PLoS Med"},{"key":"10.1016\/j.kint.2025.04.005_bib25","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/S2213-8587(23)00225-5","article-title":"Current insights and emerging trends in early-onset type 2 diabetes","volume":"11","author":"Misra","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib26","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.2337\/dc23-0834","article-title":"Age at type 2 diabetes diagnosis and cause-specific mortality: observational study of primary care patients in England","volume":"46","author":"Barker","year":"2023","journal-title":"Diabetes Care"},{"issue":"5S","key":"10.1016\/j.kint.2025.04.005_bib27","first-page":"S1","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib28","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib29","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2023-075062","article-title":"Associations between modest reductions in kidney function and adverse outcomes in young adults: retrospective, population based cohort study","volume":"381","author":"Hussain","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.kint.2025.04.005_bib30","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1093\/ckj\/sfx023","article-title":"Clinical proteomics in kidney disease as an exponential technology: heading towards the disruptive phase","volume":"10","author":"Sanchez-Ni\u00f1o","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib31","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1093\/eurheartj\/ehac683","article-title":"Prevention of cardiorenal damage: importance of albuminuria","volume":"44","author":"Ruilope","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2025.04.005_bib32","doi-asserted-by":"crossref","first-page":"557","DOI":"10.2215\/CJN.01650210","article-title":"Prediabetes, prehypertension \u2026 is it time for pre-CKD?","volume":"5","author":"Curhan","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1111\/jdi.12830","article-title":"Precision medicine in diabetes prevention, classification and management","volume":"9","author":"Xie","year":"2018","journal-title":"J Diabetes Investig"},{"key":"10.1016\/j.kint.2025.04.005_bib34","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.3390\/ijerph20021308","article-title":"Prevalence and geographic distribution of self-reported chronic kidney disease and potential risk factors in Central America","volume":"20","author":"Figueroa-Solis","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.kint.2025.04.005_bib35","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40697-015-0041-1","article-title":"A population-based study of prevalence and risk factors of chronic kidney disease in Leon, Nicaragua","volume":"2","author":"Lebov","year":"2015","journal-title":"Can J Kidney Health Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib36","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/ndt\/gfab258","article-title":"Climate change and nephrology","volume":"38","author":"Sasai","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib37","doi-asserted-by":"crossref","first-page":"5532","DOI":"10.3390\/ijerph20085532","article-title":"Environmental and social factors associated with high chronic kidney disease mortality rates in municipalities of Guatemala: an ecological study of municipal-level mortality data","volume":"20","author":"Ceron","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.kint.2025.04.005_bib38","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2215\/CJN.0000000000000312","article-title":"Chronic interstitial nephritis in agricultural communities: observational and mechanistic evidence supporting the role of nephrotoxic agrochemicals","volume":"19","author":"Holliday","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib39","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1093\/ckj\/sfac018","article-title":"Histologic characterization and risk factors for persistent albuminuria in adolescents in a region of highly prevalent end-stage renal failure of unknown origin","volume":"15","author":"Macias","year":"2022","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib40","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1093\/ckj\/sfaa229","article-title":"High prevalence of end-stage renal disease of unknown origin in Aguascalientes Mexico: role of the registry of chronic kidney disease and renal biopsy in its approach and future directions","volume":"14","author":"Gutierrez-Pena","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib41","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1186\/s12882-020-02049-4","article-title":"Evidence of selected nephrotoxic elements in Sri Lankan human autopsy bone samples of patients with CKDu and controls","volume":"21","author":"Ananda","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib42","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1186\/s12882-020-02157-1","article-title":"Impact of water quality on chronic kidney disease of unknown etiology (CKDu) in Thunukkai Division in Mullaitivu District, Sri Lanka","volume":"21","author":"Gobalarajah","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111779","article-title":"Significance of Mg-hardness and fluoride in drinking water on chronic kidney disease of unknown etiology in Monaragala, Sri Lanka","volume":"203","author":"Liyanage","year":"2022","journal-title":"Environ Res"},{"key":"10.1016\/j.kint.2025.04.005_bib44","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1016\/j.ekir.2021.07.031","article-title":"Chronic kidney disease of unknown etiology in India: what do we know and where we need to go","volume":"6","author":"John","year":"2021","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.04.005_bib45","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1159\/000492406","article-title":"Dietary salt intake is a significant determinant of impaired kidney function in the general population","volume":"43","author":"Sugiura","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2025.04.005_bib46","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1053\/j.jrn.2019.06.008","article-title":"A prospective study of dietary meat intake and risk of incident chronic kidney disease","volume":"30","author":"Mirmiran","year":"2020","journal-title":"J Ren Nutr"},{"key":"10.1016\/j.kint.2025.04.005_bib47","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1007\/s40620-020-00957-0","article-title":"Sugar- and artificially-sweetened beverages and the risks of chronic kidney disease: a systematic review and dose-response meta-analysis","volume":"34","author":"Lo","year":"2021","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib48","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3945\/jn.110.134304","article-title":"Carbohydrate nutrition is associated with the 5-year incidence of chronic kidney disease","volume":"141","author":"Gopinath","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/j.kint.2025.04.005_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195306","article-title":"Amount and pattern of physical activity and sedentary behavior are associated with kidney function and kidney damage: the Maastricht Study","volume":"13","author":"Martens","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.kint.2025.04.005_bib50","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/ageing\/afx091","article-title":"Objectively measured physical activity and kidney function in older men; a cross-sectional population-based study","volume":"46","author":"Parsons","year":"2017","journal-title":"Age Ageing"},{"key":"10.1016\/j.kint.2025.04.005_bib51","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1186\/s12882-020-01869-8","article-title":"Sedentary behaviour, physical activity, and renal function in older adults: isotemporal substitution modelling","volume":"21","author":"Kosaki","year":"2020","journal-title":"BMC Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib52","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1681\/ASN.2013040392","article-title":"Physical activity and change in estimated GFR among persons with CKD","volume":"25","author":"Robinson-Cohen","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.semnephrol.2019.02.007","article-title":"Balkan endemic nephropathy and the causative role of aristolochic acid","volume":"39","author":"Jelakovic","year":"2019","journal-title":"Semin Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib54","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.kint.2024.05.023","article-title":"Effects of microplastics on the kidneys: a narrative review","volume":"106","author":"de Oliveira","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib55","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1053\/j.ajkd.2017.12.016","article-title":"Social determinants of health: addressing unmet needs in nephrology","volume":"72","author":"Hall","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib56","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.amepre.2014.09.006","article-title":"Childhood adversity and adult chronic disease: an update from ten states and the District of Columbia, 2010","volume":"48","author":"Gilbert","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.kint.2025.04.005_bib57","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/j.socscimed.2008.06.007","article-title":"Kidney disease and the cumulative burden of life course socioeconomic conditions: the Atherosclerosis Risk in Communities (ARIC) study","volume":"67","author":"Shoham","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.kint.2025.04.005_bib58","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1001\/archpediatrics.2009.214","article-title":"Adverse childhood experiences and adult risk factors for age-related disease: depression, inflammation, and clustering of metabolic risk markers","volume":"163","author":"Danese","year":"2009","journal-title":"Arch Pediatr Adolesc Med"},{"key":"10.1016\/j.kint.2025.04.005_bib59","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.jdiacomp.2017.11.005","article-title":"Relationship between individual categories of adverse childhood experience and diabetes in adulthood in a sample of US adults: does it differ by gender?","volume":"32","author":"Campbell","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/j.kint.2025.04.005_bib60","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCULATIONAHA.114.013104","article-title":"Adverse childhood experiences and blood pressure trajectories from childhood to young adulthood: the Georgia stress and Heart study","volume":"131","author":"Su","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.04.005_bib61","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41370-021-00292-x","article-title":"Environmental metal exposures and kidney function of Guatemalan sugarcane workers","volume":"32","author":"Butler-Dawson","year":"2022","journal-title":"J Expo Sci Environ Epidemiol"},{"key":"10.1016\/j.kint.2025.04.005_bib62","doi-asserted-by":"crossref","first-page":"11001","DOI":"10.1007\/s11356-015-4324-y","article-title":"The impact of aluminum, fluoride, and aluminum-fluoride complexes in drinking water on chronic kidney disease","volume":"22","author":"Wasana","year":"2015","journal-title":"Environ Sci Pollut Res Int"},{"key":"10.1016\/j.kint.2025.04.005_bib63","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s12199-015-0464-4","article-title":"Fluoride in drinking water and diet: the causative factor of chronic kidney diseases in the North Central Province of Sri Lanka","volume":"20","author":"Dharmaratne","year":"2015","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.kint.2025.04.005_bib64","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1007\/s12199-015-0447-5","article-title":"Escalating chronic kidney diseases of multi-factorial origin (CKD-mfo) in Sri Lanka: causes, solutions, and recommendations-update and responses","volume":"20","author":"Wimalawansa","year":"2015","journal-title":"Environ Health Prev Med"},{"key":"10.1016\/j.kint.2025.04.005_bib65","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/j.kint.2023.11.034","article-title":"Pediatric kidney dimensions and risk of persistent albuminuria in Mexican adolescents","volume":"105","author":"Alcalde-Ortiz","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib66","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1093\/ndt\/gfae238","article-title":"Association of perinatal exposition to xenobiotics with kidney volume at birth","volume":"40","author":"De Santiago-Rodr\u00edguez","year":"2025","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib67","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12882-023-03232-z","article-title":"Childhood modifiable risk factors and later life chronic kidney disease: a systematic review","volume":"24","author":"Liu","year":"2023","journal-title":"BMC Nephrology"},{"key":"10.1016\/j.kint.2025.04.005_bib68","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.siny.2017.01.001","article-title":"Renal development in the fetus and premature infant","volume":"22","author":"Rosenblum","year":"2017","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.kint.2025.04.005_bib69","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/S0140-6736(23)00878-4","article-title":"National, regional, and global estimates of preterm birth in 2020, with trends from 2010: a systematic analysis","volume":"402","author":"Ohuma","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib70","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/ckj\/sfu118","article-title":"CKD hotspots around the world: where, why and what the lessons are. A CKJ review series","volume":"7","author":"Mart\u00edn-Cleary","year":"2014","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib71","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.3390\/plants10061070","article-title":"Understanding potential heavy metal contamination, absorption, translocation and accumulation in rice and human health risks","volume":"10","author":"Zakaria","year":"2021","journal-title":"Plants"},{"key":"10.1016\/j.kint.2025.04.005_bib72","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1093\/pubmed\/fdab112","article-title":"Chronic kidney disease unawareness and determinants using 1999\u20132014 National Health and Nutrition Examination Survey Data","volume":"44","author":"Florea","year":"2022","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/j.kint.2025.04.005_bib73","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1053\/j.ajkd.2020.01.007","article-title":"CKD awareness among US adults by future risk of kidney failure","volume":"76","author":"Chu","year":"2020","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib74","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1007\/s11255-023-03513-4","article-title":"Trends in chronic kidney disease awareness and related clinical and demographic characteristics from 1998 to 2018 in Koreans","volume":"55","author":"Park","year":"2023","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib75","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.amepre.2017.02.015","article-title":"State-level awareness of chronic kidney disease in the U.S","volume":"53","author":"Dharmarajan","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.kint.2025.04.005_bib76","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1093\/ckj\/sfab070","article-title":"Fighting the unbearable lightness of neglecting kidney health: the decade of the kidney","volume":"14","author":"Vanholder","year":"2021","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib77","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/ckj\/sfac199","article-title":"Chronic kidney disease as cardiovascular risk factor in routine clinical practice: a position statement by the Council of the European Renal Association","volume":"16","author":"Ortiz","year":"2023","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib78","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1161\/HYPERTENSIONAHA.121.17323","article-title":"Albuminuria testing in hypertension and diabetes: an individual-participant data meta-analysis in a global consortium","volume":"78","author":"Shin","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/j.kint.2025.04.005_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102414","article-title":"Cost-effectiveness of home-based screening of the general population for albuminuria to prevent progression of cardiovascular and kidney disease","volume":"68","author":"Pouwels","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/j.kint.2025.04.005_bib80","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1681\/ASN.2020030277","article-title":"Early detection of CKD: implications for low-income, middle-income, and high-income countries","volume":"31","author":"Tonelli","year":"2020","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib81","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2022.08.012","article-title":"Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"102","author":"de Boer","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib82","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.kint.2023.03.009","article-title":"Perspectives on early detection of chronic kidney disease: the facts, the questions, and a proposed framework for 2023 and beyond","volume":"103","author":"Levin","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib84","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1542\/pir.35.1.16","article-title":"Chronic kidney disease in children and adolescents","volume":"35","author":"Massengill","year":"2014","journal-title":"Pediatr Rev"},{"key":"10.1016\/j.kint.2025.04.005_bib85","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1016\/S0140-6736(23)00876-0","article-title":"Participation rate and yield of two home-based screening methods to detect increased albuminuria in the general population in the Netherlands (THOMAS): a prospective, randomised, open-label implementation study","volume":"402","author":"van Mil","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib86","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib87","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib88","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1056\/NEJMoa2405182","article-title":"Inflammation, cholesterol, lipoprotein(a), and 30-year cardiovascular outcomes in women","volume":"391","author":"Ridker","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib89","doi-asserted-by":"crossref","first-page":"788","DOI":"10.7326\/M22-3228","article-title":"Population-wide screening for chronic kidney disease: a cost-effectiveness analysis","volume":"176","author":"Cusick","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.kint.2025.04.005_bib90","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.nefroe.2022.07.003","article-title":"Information and consensus document for the detection and management of chronic kidney disease","volume":"42","author":"Garc\u00eda-Maset","year":"2022","journal-title":"Nefrologia (Engl Ed)"},{"key":"10.1016\/j.kint.2025.04.005_bib91","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2025.04.005_bib92","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.nefroe.2023.06.005","article-title":"The Spanish Scientific Societies before the ESC 2021 guidelines on vascular disease prevention: generalizing the measurement of albuminuria to identify vascular risk and prevent vascular disease","volume":"43","author":"Ortiz","year":"2023","journal-title":"Nefrologia (Engl Ed)"},{"key":"10.1016\/j.kint.2025.04.005_bib93","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2337\/dc22-0698","article-title":"Development and validation of prediction models of adverse kidney outcomes in the population with and without diabetes","volume":"45","author":"Grams","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib94","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.amjmed.2010.05.010","article-title":"A prediction model for the risk of incident chronic kidney disease","volume":"123","author":"Chien","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib95","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.amjmed.2011.09.009","article-title":"A risk score for chronic kidney disease in the general population","volume":"125","author":"O'Seaghdha","year":"2012","journal-title":"Am J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib96","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.2019.17379","article-title":"Development of risk prediction equations for incident chronic kidney disease","volume":"322","author":"Nelson","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib97","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1007\/s00125-006-0376-3","article-title":"End-stage renal disease risk equations for Hong Kong Chinese patients with type 2 diabetes: Hong Kong Diabetes Registry","volume":"49","author":"Yang","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.04.005_bib98","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s00125-007-0639-7","article-title":"Modified end-stage renal disease risk score for Chinese type 2 diabetic patients-the Hong Kong Diabetes Registry","volume":"50","author":"Yang","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.04.005_bib99","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2337\/dc19-1897","article-title":"Establishment and validation of a risk prediction model for early diabetic kidney disease based on a systematic review and meta-analysis of 20 cohorts","volume":"43","author":"Jiang","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib100","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1053\/j.ajkd.2021.03.026","article-title":"The promise of tubule biomarkers in kidney disease: a review","volume":"78","author":"Ix","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib101","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1093\/ckj\/sfx002","article-title":"Urinary peptide-based classifier CKD273: towards clinical application in chronic kidney disease","volume":"10","author":"Pontillo","year":"2017","journal-title":"Clin Kidney J"},{"key":"10.1016\/j.kint.2025.04.005_bib102","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(20)30026-7","article-title":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","volume":"8","author":"Tofte","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib103","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1159\/000447649","article-title":"Kidney injury marker 1 and neutrophil gelatinase-associated lipocalin in chronic kidney disease","volume":"136","author":"Castillo-Rodriguez","year":"2017","journal-title":"Nephron"},{"key":"10.1016\/j.kint.2025.04.005_bib105","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1038\/s41591-022-01869-1","article-title":"Genome-wide polygenic score to predict chronic kidney disease across ancestries","volume":"28","author":"Khan","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.04.005_bib106","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s12020-016-1014-6","article-title":"Diabetes mellitus as a risk factor for incident chronic kidney disease and end-stage renal disease in women compared with men: a systematic review and meta-analysis","volume":"55","author":"Shen","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.kint.2025.04.005_bib108","doi-asserted-by":"crossref","first-page":"4350","DOI":"10.1038\/s41467-021-24491-0","article-title":"Discovery and prioritization of variants and genes for kidney function in >1.2 million individuals","volume":"12","author":"Stanzick","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.04.005_bib109","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1038\/s41467-023-37837-7","article-title":"DNA methylation markers for kidney function and progression of diabetic kidney disease","volume":"14","author":"Li","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.04.005_bib110","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1681\/ASN.2007091025","article-title":"Urinary proteomics in diabetes and CKD","volume":"19","author":"Rossing","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib111","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/s41581-020-00348-5","article-title":"The tissue proteome in the multi-omic landscape of kidney disease","volume":"17","author":"Rinschen","year":"2021","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib112","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1038\/s41588-019-0407-x","article-title":"A catalog of genetic loci associated with kidney function from analyses of a million individuals","volume":"51","author":"Wuttke","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/j.kint.2025.04.005_bib113","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.cca.2014.08.039","article-title":"Biomarkers of renal function, which and when?","volume":"438","author":"Wasung","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/j.kint.2025.04.005_bib114","doi-asserted-by":"crossref","first-page":"6340","DOI":"10.1038\/s41467-023-41642-7","article-title":"Proteomics of CKD progression in the Chronic Renal Insufficiency Cohort","volume":"14","author":"Dubin","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.kint.2025.04.005_bib115","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1159\/000492407","article-title":"Prognostic value of urinary calprotectin, NGAL and KIM-1 in chronic kidney disease","volume":"43","author":"Seibert Felix","year":"2018","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/j.kint.2025.04.005_bib116","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1093\/jamia\/ocx065","article-title":"Implementation of a scalable, web-based, automated clinical decision support risk-prediction tool for chronic kidney disease using C-CDA and application programming interfaces","volume":"24","author":"Samal","year":"2017","journal-title":"J Am Med Inform Assoc"},{"key":"10.1016\/j.kint.2025.04.005_bib117","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib118","doi-asserted-by":"crossref","DOI":"10.1016\/j.xkme.2023.100643","article-title":"Lifestyle interventions, kidney disease progression, and quality of life: a systematic review and meta-analysis","volume":"5","author":"Neale","year":"2023","journal-title":"Kidney Med"},{"key":"10.1016\/j.kint.2025.04.005_bib119","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib120","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(14)70156-1","article-title":"Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib121","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.2215\/CJN.02180311","article-title":"Metabolic syndrome and kidney disease: a systematic review and meta-analysis","volume":"6","author":"Thomas","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib122","doi-asserted-by":"crossref","DOI":"10.1016\/j.lpm.2023.104176","article-title":"Diagnostic criteria and etiopathogenesis of type 2 diabetes and its complications: lessons from the Pima Indians","volume":"52","author":"Looker","year":"2023","journal-title":"Presse Med"},{"key":"10.1016\/j.kint.2025.04.005_bib123","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.2337\/diacare.18.7.1013","article-title":"Abnormal albuminuria as a predictor of mortality and renal impairment in Chinese patients with NIDDM","volume":"18","author":"Chan","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib124","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1046\/j.1523-1755.1998.00099.x","article-title":"The multidimensional nature of renal disease: rates and associations of albuminuria in an Australian Aboriginal community","volume":"54","author":"Hoy","year":"1998","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib125","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.2337\/diacare.21.7.1080","article-title":"High incidence of diabetic nephropathy in early-onset Japanese NIDDM patients: risk analysis","volume":"21","author":"Yokoyama","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib126","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors, and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib127","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1093\/ndt\/gfab036","article-title":"Water intake and progression of chronic kidney disease: the CKD-REIN cohort study","volume":"37","author":"Wagner","year":"2022","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib128","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1001\/jama.2018.4930","article-title":"Effect of coaching to increase water intake on kidney function decline in adults with chronic kidney disease: the CKD WIT randomized clinical trial","volume":"319","author":"Clark","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib129","article-title":"Prescribed water intake in autosomal dominant polycystic kidney disease","volume":"1","author":"Rangan","year":"2021","journal-title":"NEJM Evid"},{"key":"10.1016\/j.kint.2025.04.005_bib130","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s40620-015-0210-4","article-title":"Treatment effect, adherence, and safety of high fluid intake for the prevention of incident and recurrent kidney stones: a systematic review and meta-analysis","volume":"29","author":"Cheungpasitporn","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib131","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1001\/jamainternmed.2022.1449","article-title":"Effect of structured, moderate exercise on kidney function decline in sedentary older adults: an ancillary analysis of the LIFE study randomized clinical trial","volume":"182","author":"Shlipak","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.kint.2025.04.005_bib132","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJM199107183250302","article-title":"Physical activity and reduced occurrence of non-insulin-dependent diabetes mellitus","volume":"325","author":"Helmrich","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib133","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1001\/jama.282.15.1433","article-title":"Walking compared with vigorous physical activity and risk of type 2 diabetes in women: a prospective study","volume":"282","author":"Hu","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib134","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/j.kint.2025.04.005_bib135","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.2337\/dc22-0886","article-title":"Physical activity and risk of major diabetes-related complications in individuals with diabetes: a systematic review and meta-analysis of observational studies","volume":"45","author":"Rietz","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib136","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1093\/ndt\/gfad154","article-title":"Chronic kidney disease: the missing concept in the 2019 EULAR\/ERA-EDTA recommendations for lupus nephritis","volume":"39","author":"Rojas-Rivera","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib137","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib138","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib139","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib140","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib141","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib142","article-title":"Finerenone and chronic kidney disease outcomes in type 2 diabetes, Reply","volume":"384","author":"Bakris","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib143","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib144","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.kint.2022.08.040","article-title":"A prespecified exploratory analysis from FIDELITY examined finerenone use and kidney outcomes in patients with chronic kidney disease and type 2 diabetes","volume":"103","author":"Bakris","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib145","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1161\/CIRCULATIONAHA.121.055459","article-title":"Effect of the glucagon-like peptide-1 receptor agonists semaglutide and liraglutide on kidney outcomes in patients with type 2 diabetes: pooled analysis of SUSTAIN 6 and LEADER","volume":"145","author":"Shaman","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.kint.2025.04.005_bib146","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib147","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/ndt\/gfad009","article-title":"The rationale, design and baseline data of FLOW, a kidney outcomes trial with once-weekly semaglutide in people with type 2 diabetes and chronic kidney disease","volume":"38","author":"Rossing","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib148","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists' Consortium. Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib149","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1056\/NEJMoa042167","article-title":"Preventing microalbuminuria in type 2 diabetes","volume":"351","author":"Ruggenenti","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib150","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib151","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib152","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib153","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib154","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.2337\/dc20-0495","article-title":"Sustained lower incidence of diabetes-related end-stage kidney disease among American Indians and Alaska Natives, Blacks, and Hispanics in the U.S., 2000\u20132016","volume":"43","author":"Burrows","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib155","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib156","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1001\/jama.2018.18269","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib157","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-8587(17)30182-1","article-title":"Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial","volume":"5","author":"Cherney","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib158","doi-asserted-by":"crossref","first-page":"2350","DOI":"10.2337\/dc22-0382","article-title":"Dapagliflozin and prevention of kidney disease among patients with type 2 diabetes: post hoc analyses from the DECLARE-TIMI 58 trial","volume":"45","author":"Mosenzon","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1053\/j.ajkd.2020.06.018","article-title":"Relative and absolute risk reductions in cardiovascular and kidney outcomes with canagliflozin across KDIGO risk categories: findings from the CANVAS program","volume":"77","author":"Neuen","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib160","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib161","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2215\/CJN.14901219","article-title":"Empagliflozin and cardiovascular and kidney outcomes across KDIGO risk categories: post hoc analysis of a randomized, double-blind, placebo-controlled, multinational trial","volume":"15","author":"Levin","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib162","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib163","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib164","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib165","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib166","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib167","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib168","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/S0140-6736(21)02188-7","article-title":"Tirzepatide versus insulin glargine in type 2 diabetes and increased cardiovascular risk (SURPASS-4): a randomised, open-label, parallel-group, multicentre, phase 3 trial","volume":"398","author":"Del","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib169","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib170","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib171","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(18)30268-7","article-title":"Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial","volume":"6","author":"Muskiet","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib172","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/S2213-8587(22)00243-1","article-title":"Effects of tirzepatide versus insulin glargine on kidney outcomes in type 2 diabetes in the SURPASS-4 trial: post-hoc analysis of an open-label, randomised, phase 3 trial","volume":"10","author":"Heerspink","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib173","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.kint.2022.12.028","article-title":"Post hoc analysis of SUSTAIN 6 and PIONEER 6 trials suggests that people with type 2 diabetes at high cardiovascular risk treated with semaglutide experience more stable kidney function compared with placebo","volume":"103","author":"Tuttle","year":"2023","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib174","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc22-1889","article-title":"Effects of semaglutide on albuminuria and kidney function in people with overweight or obesity with or without type 2 diabetes: Exploratory analysis from the STEP 1, 2, and 3 Trials","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib175","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib176","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.kint.2025.04.005_bib177","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1016\/j.ekir.2024.04.028","article-title":"Effects of once-weekly semaglutide on kidney disease outcomes by KDIGO risk category in the SUSTAIN 6 trial","volume":"9","author":"Tuttle","year":"2024","journal-title":"Kidney Int Rep"},{"key":"10.1016\/j.kint.2025.04.005_bib178","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.14443","article-title":"Potential kidney protection with liraglutide and semaglutide: exploratory mediation analysis","volume":"23","author":"Mann","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.kint.2025.04.005_bib179","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3390\/ph17101299","article-title":"Glucose-lowering drugs and primary prevention of chronic kidney disease in type 2 diabetes patients: a real-world primary care study","volume":"17","author":"Rodr\u00edguez-Miguel","year":"2024","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.kint.2025.04.005_bib180","doi-asserted-by":"crossref","first-page":"3197","DOI":"10.1681\/ASN.2021050598","article-title":"Effect of low-dose methotrexate on eGFR and kidney adverse events: a randomized clinical trial","volume":"32","author":"Sparks","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib181","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1093\/ndt\/gfx377","article-title":"JAK1\/JAK2 inhibition by baricitinib in diabetic kidney disease: results from a phase 2 randomized controlled clinical trial","volume":"33","author":"Tuttle","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.kint.2025.04.005_bib182","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1053\/j.ackd.2017.12.002","article-title":"Inflammatory mechanisms as new biomarkers and therapeutic targets for diabetic kidney disease","volume":"25","author":"Alicic","year":"2018","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib183","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.kint.2022.05.012","article-title":"Molecular mechanisms and therapeutic targets for diabetic kidney disease","volume":"102","author":"Tuttle","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib184","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1093\/eurheartj\/ehab777","article-title":"Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis","volume":"43","author":"Agarwal","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.kint.2025.04.005_bib185","doi-asserted-by":"crossref","first-page":"3815","DOI":"10.1007\/s11695-018-3416-4","article-title":"The effects of bariatric surgery on renal outcomes: a systematic review and meta-analysis","volume":"28","author":"Bilha","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/j.kint.2025.04.005_bib186","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.kint.2025.04.005_bib187","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2020.0420","article-title":"Effect of gastric bypass vs best medical treatment on early-stage chronic kidney disease in patients with type 2 diabetes and obesity: a randomized clinical trial","volume":"155","author":"Cohen","year":"2020","journal-title":"JAMA Surg"},{"key":"10.1016\/j.kint.2025.04.005_bib188","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-000728","article-title":"Chronic kidney disease care models in low- and middle-income countries: a systematic review","volume":"3","author":"Stanifer","year":"2018","journal-title":"BMJ Global Health"},{"key":"10.1016\/j.kint.2025.04.005_bib189","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.2337\/dci19-0003","article-title":"From Hong Kong Diabetes Register to JADE Program to RAMP-DM for data-driven actions","volume":"42","author":"Chan","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib190","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.3862","article-title":"Effect of a web-based management guide on risk factors in patients with type 2 diabetes and diabetic kidney disease: a JADE randomized clinical trial","volume":"5","author":"Chan","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.kint.2025.04.005_bib191","doi-asserted-by":"crossref","first-page":"49","DOI":"10.2337\/dc17-0426","article-title":"Five-year effectiveness of the multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on diabetes-related complications and health service uses-a population-based and propensity-matched cohort study","volume":"41","author":"Wan","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/j.kint.2025.04.005_bib192","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003367","article-title":"Association of technologically assisted integrated care with clinical outcomes in type 2 diabetes in Hong Kong using the prospective JADE program: a retrospective cohort analysis","volume":"17","author":"Lim","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/j.kint.2025.04.005_bib193","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","volume":"10","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.kint.2025.04.005_bib194","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1053\/j.ajkd.2017.09.017","article-title":"Population health for CKD and diabetes: lessons from the Indian Health Service","volume":"71","author":"Narva","year":"2018","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib195","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.kint.2017.01.027","article-title":"Decreased incidence of end-stage renal disease in American Indians with diabetes: a model for other high-risk populations?","volume":"91","author":"Wyatt","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/j.kint.2025.04.005_bib196","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1001\/jama.2017.4046","article-title":"Assessment of global kidney health care status","volume":"317","author":"Bello","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/j.kint.2025.04.005_bib197","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40620-017-0375-0","article-title":"Effectiveness of targeted screening for chronic kidney disease in the community setting: a systematic review","volume":"31","author":"Gheewala","year":"2018","journal-title":"J Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib198","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1001\/jamacardio.2019.2974","article-title":"Association of multifaceted mobile technology\u2013enabled primary care intervention with cardiovascular disease risk management in rural Indonesia","volume":"4","author":"Patel","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.kint.2025.04.005_bib199","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1515\/cclm-2023-1239","article-title":"Clinical decision support system in laboratory medicine","volume":"62","author":"Flores","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.kint.2025.04.005_bib200","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.kint.2025.04.005_bib201","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12910-020-0459-6","article-title":"A systematic review of patient access to medical records in the acute setting: practicalities, perspectives and ethical consequences","volume":"21","author":"D'Costa","year":"2020","journal-title":"BMC Med Ethics"},{"key":"10.1016\/j.kint.2025.04.005_bib202","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1053\/j.ajkd.2021.08.021","article-title":"Challenges to shared decision making about treatment of advanced CKD: a qualitative study of patients and clinicians","volume":"79","author":"House","year":"2022","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.kint.2025.04.005_bib203","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1038\/s41581-024-00820-6","article-title":"Chronic kidney disease and the global public health agenda: an international consensus","volume":"20","author":"Francis","year":"2024","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/j.kint.2025.04.005_bib204","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1002\/hec.4635","article-title":"The effect of health financing systems on health system outcomes: a cross-country panel analysis","volume":"32","author":"Gabani","year":"2023","journal-title":"Health Econ"}],"container-title":["Kidney International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825003345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0085253825003345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T04:42:52Z","timestamp":1762231372000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0085253825003345"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":200,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S0085253825003345"],"URL":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.005","relation":{},"ISSN":["0085-2538"],"issn-type":[{"value":"0085-2538","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing chronic kidney disease and maintaining kidney health: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference","name":"articletitle","label":"Article Title"},{"value":"Kidney International","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.kint.2025.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Kidney Disease: Improving Global Outcomes (KDIGO). Published by Elsevier Inc. on behalf of the International Society of Nephrology.","name":"copyright","label":"Copyright"}]}}